Zobrazeno 1 - 10
of 24
pro vyhledávání: '"V A Gubkina"'
Publikováno v:
Сахарный диабет, Vol 25, Iss 2, Pp 166-173 (2022)
Background: Sulfonylureas (SU) are often used for second and third line type 2 diabetes mellitus (T2DM) therapy. Currently, there are no unified recommendations governing the choice of drugs for the second line therapy. This requires clarification.Ai
Externí odkaz:
https://doaj.org/article/bf63e8e28fc44b4a8e2eea45fe9fa168
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 7, Pp 500-509 (2020)
In type 2 diabetes mellitus (T2DM), the development and progression of cardiovascular diseases occurs, which allows it to be considered as a cardiorenal metabolic syndrome. This should be taken into account when choosing hypoglycemic drugs. Patients
Externí odkaz:
https://doaj.org/article/3eb11e80cb274a84b4d831d04cb3369b
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 2, Pp 126-137 (2019)
Background: Sleep breathing disorders can be an additional risk factor for the development of cardiovascular disorders in patients with endocrine disorders.Aim: To assess the sleep apnea risk in patients with various endocrine disorders undergoing in
Externí odkaz:
https://doaj.org/article/76b4947984c14b82a736173f465c0b39
Chronic obstructive pulmonary disease and chronic heart failure in elderly people: literature review
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 23, Iss 2, Pp 11-15 (2016)
The article provides literature review on the subject: chronic obstructive pulmonary disease: pathogenesis, principles of treatment, the course of heart failure in elderly people with comorbide pathology (chronic obstructive pulmonary disease and car
Externí odkaz:
https://doaj.org/article/cef9a29bcd034a5184796d9127035953
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 32, Pp 12-16 (2016)
Background: It is extremely important to have information about the main epidemiological indicators characterizing the situation on diabetes mellitus (DM) in Moscow Region. Aim: To assess the dynamics of the main epidemiological indicators of type 1
Externí odkaz:
https://doaj.org/article/41745bb2b0a64525b9132bee611323cf
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 7, Pp 500-509 (2020)
In type 2 diabetes mellitus (T2DM), the development and progression of cardiovascular diseases occurs, which allows it to be considered as a cardiorenal metabolic syndrome. This should be taken into account when choosing hypoglycemic drugs. Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1341cc82e095b607e3ed987765f55cb
https://doi.org/10.18786/2072-0505-2020-48-056
https://doi.org/10.18786/2072-0505-2020-48-056
Autor:
Alexander Vasil'evich Dreval', Inna Vladimirovna Misnikova, V A Gubkina, M V Agal'tsov, S I Fedorova
Publikováno v:
Сахарный диабет, Vol 16, Iss 1, Pp 71-77 (2013)
Aims. To assess the risk for sleep apnea in patients with various types of glycemic disorders by means of Epworth Sleepiness Scale andSleep Apnea Screening Questionnaire. Materials and Methods. We examined 744 residents of Mozhaisk Region, that were
Externí odkaz:
https://doaj.org/article/e1c9abba1b65403dbdd8cc3b8de8d54e
Publikováno v:
Остеопороз и остеопатии, Vol 8, Iss 1, Pp 7-11 (2005)
У 30 больных (в возрасте 20-46 лет) терминальной хронической почечной недостаточностью (ТХПН), получающих лечение перитонеальным диализом (
Externí odkaz:
https://doaj.org/article/8e78932ce3ce4204bc9b8bfee864a7a8
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 2, Pp 126-137 (2019)
Background: Sleep breathing disorders can be an additional risk factor for the development of cardiovascular disorders in patients with endocrine disorders.Aim: To assess the sleep apnea risk in patients with various endocrine disorders undergoing in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d14819d9a66d7bd3a87291f0c4ebea97
https://doi.org/10.18786/2072-0505-2019-47-023
https://doi.org/10.18786/2072-0505-2019-47-023
Publikováno v:
Problemy endokrinologii. 66(5)
BACKGROUND: The prevalence of T2DM is steadily increasing not only among the elderly, but also at a young age. T2DM is preceded by a long period of significant metabolic changes with the development of insulin resistance and в-cell dysfunction. To r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db29b891863cc7e289065befb8e4f066
https://pubmed.ncbi.nlm.nih.gov/33369376
https://pubmed.ncbi.nlm.nih.gov/33369376